ogy (Beverly, MA, U.S.A.), while those against Cox-2, bactin, and histone H1 were from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.).
Extraction and Isolation of cis-Ampelopsin E The dried seeds of Paeonia suffruticosa (2.8 kg) were purchased from Qingping Herb Market, Guangzhou in August 2009 and the voucher specimen (No. 20090802) has been deposited in School of Life Science, Liaoning University, Shenyang, China. After pulverized, the seeds were extracted by MeOH (4ϫ5 l) at room temperature. The MeOH extract was concentrated under reduced pressure at 60°C to yield a brown residue (ca. 400 g). The dried crude extract was dissolved in 1 l of water and subjected to liquid-liquid extraction with equal volumes of n-hexane, CHCl 3 , and EtOAc in a successive order. The EtOAc fraction (96 g) was further separated by silica gel column chromatography with CHCl 3 -MeOH (90 : 10→60 : 40, v/v) as the mobile phase to afford 8 fractions. The subfraction 5 was loaded onto a semi-preparative reversed phase HPLC using H 2 O/MeOH [flow rate: 4 ml/min, H 2 O : MeOH 85 : 15 (0 min)→40 : 60 (25 min)] as eluting solvent to yield three pure compounds. Among them, compound 2 (t R ϭ11.7 min, 55 mg), an amorphous powder, was identified to be cis-ampelopsin E by its IR, UV, 1 H-NMR, 13 C-NMR and comparison with spectroscopic data reported in the literatures. 24, 25) The compound was accurately weighed and dissolved in dimethyl sulfoxide (DMSO) to constitute 20 mm of stock solutions that were stored at Ϫ20°C.
Cell Culture RAW 264.7 (mouse leukaemic monocyte macrophage cells) cells were purchased from the American Type Culture Collection (Rockville, MD, U.S.A.) and grown in Dulbecco's modified Eagle's medium (DMEM; purchased from Sigma-Aldrich Co., MO, U.S.A.) supplemented with 10% (v/v) fetal bovine serum (Hyclone, UT, U.S.A.), 3.7 g/l sodium bicarbonate, 100 mg/ml streptomycin and 100 U/ml penicillin G. The cells were incubated at 37°C in a humidified atmosphere containing 5% CO 2 . In order to reduce the serum effect, the culture medium was changed to fresh serum-free medium before each treatment.
Cell Viability Assay The effect of cis-ampelopsin E on the viability of RAW 264.7 cells was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich) assay. Briefly, RAW 264.7 cells were seeded in 96-well tissue culture plates (5000 cells per well) and cultured for 48 h. Medium containing pure tested compounds or DMSO vehicle was added in triplicate for each concentration and time points. After treatment, cell viability was analyzed by addition of MTT following the manufacturers' protocol. The absorbance of MTT was determined at 590 nm using a Tecan Spectra Fluor spectrophotometer (MTX Lab Systems Inc., Vienna, VA, U.S.A.). Absorbance values were normalized to relevant medium and vehicle controls.
Measurement of Nitric Oxide Nitric oxide production was measured as nitrite (a stable metabolite of NO) concentrations in the culture medium using the Griess reagent system. Briefly, RAW 264.7 cells were seeded and cultured in 24-well plates till 70-80% confluence. Culture medium was replaced by serum-free DMEM before the addition of different concentrations of cis-ampelopsin E. Following 30 min of treatment, 1 mg/ml LPS was added and the cells were further incubated for 24 h. The medium was gently collected and centrifuged (4000 g, 5 min, 4°C), after which 100 ml of the cleared medium was added to an equal volume of Greiss reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride, and 2.5% phosphoric acid) (Fluka BioChemika, Switzerland). The mixture was agitated and kept in the dark at room temperature for 15 min. The absorbance was read at 540 nm using a plate reader. Absorbance readings of a range of known nitrite concentrations derived from sodium nitrite (Sigma-Aldrich Co., MO, U.S.A.) were predetermined to obtain a standard plot, from which the nitrite concentrations detected in the collected medium samples were determined and expressed in micromoles per liter.
cPLA2 Activity and PGE2 Analysis RAW 264.7 cells were cultured in DMEM medium containing 10% fetal bovine serum at 37°C for 24 h to allow cell attachment, after which the culture medium was replaced with serum-free DMEM. Different concentrations of cis-ampelopsin E were introduced 30 min before LPS (1 mg/ml) stimulation. Following another 6 h's incubation, the cells were harvested and prepared in homogenization buffer (50 mM N-(2-hydroxyethyl)-piperazine-NЈ-2-ethanesulfonic acid (HEPES), pH 7.4, containing 1 mM ethylenediaminetetraacetic acid (EDTA)). cPLA2 activity in RAW 264.7 macrophages was measured using a commercially available assay kit (cPLA2 assay kit, Cayman Chemical Co.) following the manufacturer's instructions. To perform the PGE2 analysis, the cis-ampelopsin E pretreated and LPS challenged RAW 264.7 cells were maintained in serum-free medium for 24 h. The conditioned medium was collected and processed for PGE2 quantification using a specific enzyme immunoassay kit (Cayman Chemical Co.) following the manufacturer's instructions.
NF-k kB-Dependent Luciferase Reporter Assay RAW 264.7 cells seeded in 24-well culture plates (60% confluence) were cotransfected with 0.7 mg pNF-kB-Luc plasmids (PathDetect luciferase cis-reporting system containing NFkB enhancer elements; purchased from Stratagene, La Jolla, CA) and 14 ng pRL-CMV (Promega) per well using GeneJuice ® transfection reagent (Novagen, Nottingham, U.K.). Transfected cells were then maintained in serum-free medium for 12 h, pretreated with cis-ampelopsin E for 30 min, followed by LPS stimulation for another 8 h. Firefly and renilla luciferase activities were assayed using the Dual Luciferase Assay System (Promega, Madison, WI, U.S.A.) following manufacturer's instructions. Results were expressed as firefly luciferase activity normalized to renilla luciferase activity.
RNA Extraction and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) RNA extraction was carried out using a RNeasy® Mini Kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. Total RNA (2 mg) from each sample was subjected to reverse transcription using a RevertAid TM First Strand cDNA Synthesis Kit (Fermentas, Hanover, MD, U.S.A.). PCR amplification was performed in a 20 ml reaction solution which contained 2 ml generated cDNA, 2 ml deoxyribosenucleotide triphosphate (2 mM), 0.2 ml Taq DNA Polymerase (New England Biolabs) and 1 ml of each specific sense and anti-sense primers (5 nM). PCR was run for 30 cycles of 94°C for 15 s (denaturation), 55°C for 15 s (annealing) and 72°C for 30 s (extension). The PCR products were subjected to electrophoresis on 1.2% agarose gels containing ethidium bromide and images were captured under UV light in a Bio-Rad ChemiDoc imaging system (Hercules, CA, U.S.A.). The primer sequences and product size were 5Ј-GTG TTC CAC CAG GAG ATG TTG-3Ј (forward) and 5Ј-CTC CTG CCC ACT GAG TTC GTC-3Ј (reverse) for iNOs (576 bp). Housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH), whose primer sequences were forward 5Ј-ACC ACA GTC CAT GCC ATC AC-3Ј, reverse 5Ј-TCC ACC ACC CTG TTG CTG TA-3Ј (452 bp) was used as an internal reference to indicate equal loading.
Preparation of Whole Cell Lysates and Nuclear Extracts Treated cells were washed with ice-cold PBS and lysed with lysis buffer [25 mM Tris-HCl (pH 7.5), 100 mM NaCl, 2.5 mM EDTA, 2.5 mM EGTA, 20 mM NaF, 1 mm Na 3 VO 4 , 20 mM sodium b-glycerophosphate, 10 mM sodium pyrophosphate, 0.5% triton X-100] containing freshly added protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). For preparation of nuclear extracts, cells were scraped, washed with PBS and resuspended in ice-cold buffer containing 10 mM HEPES (pH 7.9), 10 mM KCl, 0.5 mM dithiothreitol (DTT), 0.2 mM phenylmethylsulfonyl fluoride (PMSF), 1.5 mM MgCl 2 and 1.2% Nonidet P-40, and allowed to swell on ice for 10 min. Following centrifugation at 3300ϫg for 5 min at 4°C, the supernatant was used as the cytosolic extract. The nuclear pellets were extracted in nuclear extraction buffer containing 20 mm HEPES (pH 7.9), 0.4 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% glycerol, 0.5 mM PMSF, 0.5 mM DTT, 1 mg/ml leupeptin, and 1 mg/ml aprotinin for 30 min on ice, and centrifuged at 12000ϫg for 30 min. The supernatant was used as the nuclear extract and stored at Ϫ80°C before use. 26) Protein concentrations of precleared lysates were determined using a modified Bradford assay (Bio-Rad Laboratories).
Western Blot Analysis Proteins in whole cell lysates and nuclear fractions were electrophoresed on a sodium dodecyl sulfate (SDS)-polyacrylamide gel, and transferred to a nitrocellulose membrane. Nonspecific binding was blocked with 5% nonfat milk for 1 h at room temperature. After immunoblotting with the first specific antibodies, membranes were washed three times with TBST and incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h. Membranes were then visualized by enhanced chemiluminescence [SuperSignal West Femto (Pierce, Rockford, IL, U.S.A.)]. To make sure equal amounts of sample protein were applied for electrophoresis and immunoblotting, b-actin was used as an internal control.
Statistical Analysis Band intensities of the Western blot films were quantified by Image J software (NIH). Numerical data are indicated as meanϮS.D. of different determinations. Statistical significance between treatment and control groups was analyzed using a two-tailed Student's t-test. Values of pϽ0.05 were considered statistically significant.
RESULTS

cis-Ampelopsin E Inhibits LPS-Induced Nitric Oxide
Production from RAW 264.7 Cells without Reducing the Cells' Viability At basal level, the macrophage cells produced 2.8Ϯ0.6 mM of NO (measured as nitrite). When 1 mg/ml of LPS was introduced, the NO level was increased dramatically up to 35.3Ϯ4.3 mM at 24 h, which was more than 12-fold of the basal level. Pretreatment of the cells with different concentrations of cis-ampelopsin E 30 min before the LPS stimulation could reduce the nitric oxide production in a dose-dependent manner, with IC 50 value being around 16 mM (Fig. 2A) . Examination of the cytotoxicity of cis-ampelopsin E in RAW 264.7 macrophages by the MTT assay indicated that while 50 mM of cis-ampelopsin E could reduce cell viability to 88% of the control group, cis-ampelopsin E did not affect the viability of cells at concentrations of 2 to 20 mM (Fig. 2B) .
cis-Ampelopsin E Inhibits iNOS mRNA and Protein Expressions in LPS-Stimulated RAW 264.7 Cells The followed RT-PCR analysis and Western blot analysis conducted on the cis-ampelopsin E pre-treated RAW 264.7 cells revealed that cis-ampelopsin E caused a concentration-dependent inhibition of iNOS mRNA (Fig. 3A) and protein (Fig. 3B ) expression in the LPS-stimulated RAW 264.7 cells. The results indicated that the reduction in the nitric oxide release occurred in parallel with the comparable inhibition of iNOS enzyme expression.
cis-Ampelopsin E Inhibits LPS-Induced NF-k kB Transcriptional Activity Since NF-kB activity plays a key role in the induction of iNOS by LPS, the effect of cis-ampelopsin E on this transcription was examined. As shown in In accord with the luciferase activity data, Western blot analysis on the nuclear extract showed that cis-ampelopsin E reduced the content of transcription factor p65 translocated into the nucleus (Fig.  4B) .
cis-Ampelopsin E Inhibits the Phosphorylation of Ik kBa a by Suppressing the LPS-Induced Phosphorylation of IKK
Under basal conditions, NF-kB associates with its inhibitory protein, inhibitor of kappaBa (IkBa), and thus is sequestered in the cytoplasm in an inactive form. Upon stimulation, IkB kinase (IKK) complex could mediate phosphorylation and subsequent proteosomal degradation of IkBa, causing the release of NF-kB p65 subunit. As shown in Fig.  5A , LPS-induced degradation of IkBa was inhibited by pretreatment of the cells with 5 to 20 mM of cis-ampelopsin E; the LPS-induced accumulation of phosphorylated IkBa at serine 32 was also decreased by 5 to 20 mM of cis-ampelopsin E in a dose-dependent manner. Further western blot analysis on the upstream signal pathway involving IKK showed that whereas the total protein level of IKKa remained largely unchanged, the LPS-induced activation of IKKa/b to the phosphorylated form at serine 176 and 180 was suppressed dose dependently by cis-ampelopsin E (Fig. 5B) .
cis-Ampelopsin E Inhibits LPS-Induced Cox-2 Expression, cPLA2 Activation and PGE2 Production The arachidonic acid (AA) cascade lies downstream of NF-kB signaling pathway and is initiated via the release of phospholipase A 2 (PLA 2 ). Activation of NF-kB signaling pathway activates PLA 2 to hydrolyze glycerophospholipids to release AA, which is next metabolized through the cyclooxygenase 27) or lipoxygenase (Lox) pathways. As shown in Figs. 6A and B, the LPS-induced high expression of Cox-2 was inhibited by 5 to 20 mM of cis-ampelopsin E in a dose-dependent manner; the enhanced cLPA2 activity was also lowered to a comparable level with the general PLA 2 inhibitor, 7,7-dimethyl-5,8-eicosadienoic acid (DEDA) when the cells were pretreated with 20 mM of cis-ampelopsin E. In addition, cis-ampelopsin E effectively suppressed LPS-induced PGE2 production. U0126, a highly selective inhibitor of both MEK1 and MEK2, was reported to inhibit Cox-2 expression as well as PGE2 production and used here as a positive control (Fig. 6C) . 
DISCUSSION
Following inflammatory stimuli, macrophage has been induced to produce excessive NO, a molecule synthesized from L-arginine by the enzyme nitric oxide synthase. 20) Three distinct isoforms of NOS have been isolated, namely neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS).
20) The first two isoforms, which are constitutively expressed under "basal" conditions, are calcium-dependent. In contrast, iNOS is a calcium-independent enzyme that is involved in inflammatory reactions and only produced by many cell types in response to endotoxins or cytokines. When high concentration of NO is secreted, in particular as derived from iNOS, it not only aids in leukocyte recruitment, but also reacts with reactive oxygen species to produce reactive nitrogen species, and ultimately disrupts many cellular processes through direct oxidative effects and/or alteration of protein conformation via a process termed nitration. [21] [22] [23] In cultures of the murine macrophage cell line RAW 264.7, cisampelopsin E, a stilbene isolated from the seeds of Paeonia suffruticosa, suppressed the LPS-induced production of NO. In our studies, cis-ampelopsin E also abolished the LPS-induced expression of both iNOS protein and mRNA in a parallel, concentration-dependent manner.
The activation of NF-kB is critical for the induction of iNOS gene expression in cells stimulated with LPS, and the degradation of I-kBa and I-kBb proteins plays a critical role in NF-kB activation. 28) When LPS was introduced into the medium, it is delivered to CD14 by LPS binding protein (LBP) and transferred to myeloid differentiation protein 2 Activation and PGE2 Production RAW 264.7 cells were cultured in DMEM medium containing 10% fetal bovine serum at 37°C for 24 h to allow cell attachment, after which the culture medium was replaced with serum-free DMEM. Different concentrations of cis-ampelopsin E were introduced 30 min before LPS (1 mg/ml) stimulation. The cells were incubated for another 6 h or 24 h. (A) Effect of cis-ampelopsin E on the expression of Cox-2 protein levels. After the cell were challenged with LPS for 24 h, whole cell lysates were prepared and immunoblotted with anti-Cox-2 antibody. b-Actin immunodetection was carried out to verify equal protein loading. (B) Effect of cis-ampelopsin E on cPLA2 enzyme activation. The pretreated RAW 264.7 cells were challenged with LPS for 6 h before collecting cell lysates. cPLA 2 enzyme activity was determined using a cPLA 2 assay kit as detailed in materials and methods. A general PLA 2 inhibitor DEDA was used as positive control in this experiment. (C) Effect of cis-ampelopsin E on PGE2 production from LPS-induced RAW 264.7 cells. After the cells were challenged by LPS for 24 h, the medium was collected and subjected to PGE2 analysis using a PGE2 assay kit as detailed in Materials and Methods. Each column shows the meanϮS.D. of three independent experiments. ## pϽ0.01 versus DMSO control; * * pϽ0.01 versus LPS onlytreatment.
(A) (B) (C) (MD-2) to form a monomeric endotoxin : MD-2 complex. The formed complex binds and activates Toll-like receptor 4 (TLR4) to induce a signaling cascade including the activation of NF-kB. NF-kB is a dimeric transcription factor that is formed by the dimerization of proteins in the Rel family. In unstimulated cells, the NF-kB dimers are sequestered in the cytoplasm by a family of inhibitors (IkBs, inhibitor of kB) and remains inactive. Activation of the NF-kB is initiated by the signal-induced degradation of IkB proteins. This occurs primarily via activation of the upstream kinase called the IkB kinase (IKK). IKK is composed of a heterodimer of the catalytic IKK alpha and IKK beta subunits. Exposure of cells to inflammatory stimuli leads to activation of IKK complex, which in turn phosphorylates IkBa. Consequently, phosphorylated IkBa is recognized and degraded by ubiquitin-proteasome machinery. The degradation of IkBa allows NF-kB p65 subunit to translocate freely to the nucleus where it binds to DNA and induces transcription. 26, 29) In this study, we found that cis-ampelopsin E effectively inhibited LPSinduced p65 nuclear translocation, prevented LPS-induced IkBa degradation and decreased IkBa phosphorylation. These inhibitory effects of cis-ampelopsin E on NF-kB signaling can be traced to its inhibition on IKKa/b phosphorylation. Whether cis-ampelopsin E achieved this inhibition effect by competitive binding of TLR4 with LPS or by blockage of upstream cascade of IKK is under further investigation.
Activation of NF-kB also up-regulates the expression of genes that encode inflammatory cytokines, adhesion molecules, chemokines, growth factors, and inducible enzymes such as PLA 2 s and cyclooxygenase (Cox) . 29) PLA 2 s are from several unrelated protein families sharing common enzymatic activities. Among which, secreted and cytosolic phospholipase A 2 (sPLA 2 and cPLA 2 ) are the two most notable families. Stimulation of inflammatory cells activates PLA 2 to hydrolyze glycerophospholipids and release arachidonic acid (AA). 30, 31) AA is next metabolized through the cyclooxygenase (Cox) 32) or lipoxygenase (Lox) pathways [33] [34] [35] to prostaglandin H 2 (PGH 2 ), the precursor of the series-2 prostanoids. There are two isoforms of cyclooxygenase, namely Cox-1 and Cox-2. While Cox-1 is constitutively expressed in many cells types, Cox-2 is an inducible enzyme. It is undetectable in most normal tissues and only becomes abundant in activated macrophages and other cells at sites of inflammation. It was also reported to be upregulated in various carcinomas and to have a central role in tumorigenesis. Therefore, inhibition of Cox-2 expression plays pivotal roles in anti-inflammatory therapy. In this study, cis-ampelopsin E dose-dependently inhibited the LPS-induced high expression of Cox-2; the enhanced cPLA2 activity was also lowered to a comparable level with DEDA, a general PLA 2 inhibitor. The production of prostaglandin E2 (PGE2), which is one of the most important series-2 prostanoids and plays crucial roles in various biological events such as neuronal function, vascular hypertension, tumorigenesis and inflammation, was also effectively suppressed by cis-ampelopsin E. These results, taken together, suggested that cis-ampelopsin E poses potential anti-inflammatory activities via blockage of the NF-kB signaling pathway.
In conclusion, our study provided evidence that cis-ampelopsin E at sub-lethal concentrations inhibits nitric oxide release from LPS-stimulated macrophages. The reduction in the nitric oxide release occurred in parallel with the comparable inhibition of iNOS enzyme expression, which was achieved by cis-ampelopsin E's suppressive effect on NF-kB signaling activation (summarized in Fig. 7) . Moreover, we revealed that cis-ampelopsin E inhibited LPS-induced Cox-2 expression, cPLA2 activation and PGE2 production, suggesting a potential anti-inflammatory activity. cis-Ampelopsin E inhibited LPS-induced IKK phosphorylation, leading to prevention of IkBa phosphorylation. As a result, p65 nuclear translocation and NF-kB dependent transcriptional activity were suppressed. By reducing iNOs and Cox-2 expression, cis-ampelopsin E brought about an inhibition on LPS-induced inflammatory reaction.
